共 173 条
[1]
El-Serag HB(1999)Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 745-750
[2]
Mason AC(2010)Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort Radiology 255 955-965
[3]
Lewandowski RJ(2005)Management of hepatocellular carcinoma Hepatology (Baltimore, Md) 42 1208-1236
[4]
Mulcahy MF(2008)Diagnosis and treatment of hepatocellular carcinoma Gastroenterology 134 1752-1763
[5]
Kulik LM(2017)Update on embolization therapies for hepatocellular carcinoma Curr Oncol Rep 19 40-Cr195
[6]
Riaz A(2011)Transarterial chemoembolization of child-a hepatocellular carcinoma: drug-eluting bead TACE (DEB TACE) vs. TACE with cisplatin/lipiodol (cTACE) Med Sci Monit 17 Cr189-1335
[7]
Ryu RK(2012)Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using drug eluting beads. Implications for clinical practice and trial design J Hepatol 56 1330-253
[8]
Baker TB(2011)Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma Australas Radiol 53 246-481
[9]
Ibrahim SM(2007)Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics J Hepatol 46 474-1108
[10]
Abecassis MI(2007)A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead Clin Gastroenterol Hepatol 5 1100-60